-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Intraday Session
Share
Listen to the news

Gainers

  • Akanda (NASDAQ:AKAN) stock rose 42.6% to $1.94 during Monday's regular session. The market value of their outstanding shares is at $3.5 million.
  • CEL-SCI (AMEX:CVM) shares increased by 30.46% to $1.67. The company's market cap stands at $22.5 million.
  • Cardiff Oncology (NASDAQ:CRDF) stock increased by 21.63% to $0.88. The company's market cap stands at $56.4 million. As per the press release, Q3 earnings came out 2 days ago.
  • Nomad Power Solutions (NASDAQ:NMAD) shares rose 21.44% to $2.85. The market value of their outstanding shares is at $42.9 million.
  • Fractyl Health (NASDAQ:GUTS) shares rose 15.92% to $1.05. The company's market cap stands at $11.9 million. As per the news, the Q3 earnings report came out 2 days ago.
  • DarioHealth (NASDAQ:DRIO) stock increased by 15.07% to $1.45. The company's market cap stands at $14.2 million. As per the news, the Q3 earnings report came out 2 days ago.

Losers

  • Basel Medical Group (NASDAQ:BMGL) shares declined by 35.4% to $0.3 during Monday's regular session. The company's market cap stands at $6.3 million.
  • Microbot Medical (NASDAQ:MBOT) shares decreased by 34.8% to $0.64. The company's market cap stands at $65.7 million. As per the news, the Q3 earnings report came out today.
  • Xtant Medical Holdings (AMEX:XTNT) shares fell 30.04% to $0.19. The company's market cap stands at $38.1 million. As per the press release, Q3 earnings came out today.
  • Rein Therapeutics (NASDAQ:RNTX) stock decreased by 26.49% to $0.41. The market value of their outstanding shares is at $47.6 million. As per the news, the Q3 earnings report came out today.
  • Virax Biolabs Group (NASDAQ:VRAX) shares decreased by 24.92% to $0.46.
  • Accendra Health (NYSE:ACH) shares decreased by 24.02% to $0.1. The company's market cap stands at $10.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending